Evidence map›Paper›PMID 30719338›Full record

ArticleJournal of ophthalmology2019

Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors.

Bin Zheng, Yan Chen, Lifeng Chen, Huan Chen, Jingwei Zheng, Feng Chen, Zongming Song, Lin Fu, Xuting Hu, Jiandong Pan and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Stand-alone pars plana vitrectomy versus pars plana vitrectomy with retinopexy for retinal vasoproliferative tumors.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Bin Zheng *The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Yan Chen *Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Lifeng ChenEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Huan ChenEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Jingwei ZhengEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Feng ChenEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Zongming SongEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Lin FuEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.ORCID 0000-0003-3773-7340
Xuting HuEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Jiandong PanEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Hengli LianEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Lijun ShenEye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.ORCID 0000-0002-7518-2932
Qiuming LiThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.ORCID 0000-0003-1944-6216
Wenzhou Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT).

methodsRetrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA).

resultsAltogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (

conclusionsRVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT.

Identifiers

PMID30719338
PMCPMC6334322
OpenAlexW2907682476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.